Comparison of vonoprazan bismuth‐containing triple therapy with quadruple therapy in Helicobacter pylori‐infected treatment‐naive patients: a prospective multicenter randomized controlled trial

Documenti analoghi

• Evaluating vonoprazan bismuth‐containing triple therapy versus quadruple therapy for Helicobacter pylori
  di: W‐Z Tang, et al.
  Pubblicazione: (2024)
• Comparative efficacy of Helicobacter pylori eradication therapy between tegoprazan‐based concomitant and bismuth quadruple therapies: A real‐world evidence
  di: Yoon Suk Jung, et al.
  Pubblicazione: (2024)
• A Multisite Fusion‐Based Deep Convolutional Neural Network for Classification of Helicobacter pylori Infection Status Using Endoscopic Images: A Multicenter Study
  di: Duwei Dai, et al.
  Pubblicazione: (2025)
• Development and validation of a prognostic model for 90‐day survival in patients with alcohol‐associated cirrhosis and acute decompensation
  di: Hui Quan, et al.
  Pubblicazione: (2024)
• Efficacy and safety of tegoprazan‐ and rabeprazole‐based concomitant therapies for Helicobacter pylori infection: Real‐world evidence
  di: Byung Wook Jung, et al.
  Pubblicazione: (2024)